These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32622650)

  • 21. ASPECT Score and Its Application to Vasospasm in Aneurysmal Subarachnoid Haemorrhage: a Case-Control Study.
    Bautista M; Burger R; Anderson IA; Mathew RK
    Transl Stroke Res; 2023 Feb; 14(1):94-99. PubMed ID: 35943718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral vasospasm following arteriovenous malformation rupture: a population-based cross-sectional study.
    Dicpinigaitis AJ; Feldstein E; Shapiro SD; Kamal H; Bauerschmidt A; Rosenberg J; Amuluru K; Pisapia J; Dangayach NS; Liang JW; Bowers CA; Mayer SA; Gandhi CD; Al-Mufti F
    Neurosurg Focus; 2022 Jul; 53(1):E15. PubMed ID: 35901745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Neurological Outcomes Related to Aneurysmal Subarachnoid Hemorrhage and Onsite Access to Neurointerventional Radiology.
    Mogollon JP; Smoll NR; Panwar R
    World Neurosurg; 2018 May; 113():e29-e37. PubMed ID: 29410100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Perfusion Computed Tomography Scan for Prediction of Vasospasm and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.
    Starnoni D; Maduri R; Hajdu SD; Pierzchala K; Giammattei L; Rocca A; Grosfilley SB; Saliou G; Messerer M; Daniel RT
    World Neurosurg; 2019 Oct; 130():e743-e752. PubMed ID: 31284055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Bruder N; Higashida R; Santin-Janin H; Dubois C; Aldrich EF; Marr A; Roux S; Mayer SA
    BMC Neurol; 2022 Dec; 22(1):492. PubMed ID: 36539711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and Predictors of Angiographic Vasospasm, Symptomatic Vasospasm and Cerebral Infarction in Chinese Patients with Aneurysmal Subarachnoid Hemorrhage.
    Mijiti M; Mijiti P; Axier A; Amuti M; Guohua Z; Xiaojiang C; Kadeer K; Xixian W; Geng D; Maimaitili A
    PLoS One; 2016; 11(12):e0168657. PubMed ID: 27977801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) and Risk of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
    Griessenauer CJ; Chua MH; Hanafy KA; Baffour YT; Chen R; LeBlanc RH; Patel AS; Salem M; Karumanchi SA; Xu D; Thadhani R; Ogilvy CS; Thomas AJ
    World Neurosurg; 2017 Dec; 108():84-89. PubMed ID: 28867315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients with Aneurysmal Subarachnoid Hemorrhage (HOMA): study protocol for a randomized controlled trial.
    Lin F; Li R; Chen Y; Yang J; Wang K; Jia Y; Han H; Hao Q; Shi G; Wang S; Zhao Y; Chen X
    Trials; 2024 Jun; 25(1):377. PubMed ID: 38863026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasospasm and delayed cerebral ischaemia in patients with spontaneous subarachnoid haemorrhage (aneurysmal and pretruncal non-aneurysmal): a centre's perspective.
    Balasekaran N; Soelar SA; Anbarasen L; Cham CY; Rajandram R; Sia SF
    Med J Malaysia; 2021 Jan; 76(1):17-23. PubMed ID: 33510103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Shen J; Shen J; Zhu K; Zhou H; Tian H; Yu G
    World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early predictors of prolonged stay in a critical care unit following aneurysmal subarachnoid hemorrhage.
    Witiw CD; Ibrahim GM; Fallah A; Macdonald RL
    Neurocrit Care; 2013 Jun; 18(3):291-7. PubMed ID: 23371849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia.
    Nagahama Y; Allan L; Nakagawa D; Zanaty M; Starke RM; Chalouhi N; Jabbour P; Brown RD; Derdeyn CP; Leira EC; Broderick J; Chimowitz M; Torner JC; Hasan D
    J Neurosurg; 2018 Sep; 129(3):702-710. PubMed ID: 29099296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low neurologic intensive care unit hemoglobin as a predictor for intra-arterial vasospasm therapy and poor discharge modified Rankin Scale in aneurysmal subarachnoid haemorrhage-induced cerebral vasospasm.
    Bell DL; Kimberly WT; Yoo AJ; Leslie-Mazwi TM; Rabinov JD; Bell JE; Mehta BP; Hirsch JA
    J Neurointerv Surg; 2015 Jun; 7(6):438-42. PubMed ID: 24814068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of intrathecal milrinone injection via lumbar catheter on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Koyanagi M; Fukuda H; Lo B; Uezato M; Kurosaki Y; Sadamasa N; Handa A; Chin M; Yamagata S
    J Neurosurg; 2018 Mar; 128(3):717-722. PubMed ID: 28298035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-Terminal Proarginine Vasopressin is Associated with Disease Outcome and Mortality, but not with Delayed Cerebral Ischemia in Critically Ill Patients with an Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study.
    van Oers JAH; Ramnarain D; Oldenbeuving A; Vos P; Roks G; Kluiters Y; Beishuizen A; de Lange DW; de Grooth HJ; Girbes ARJ
    Neurocrit Care; 2022 Dec; 37(3):678-688. PubMed ID: 35750931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. External validation of the Practical Risk Chart for the prediction of delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage.
    Foreman PM; Chua MH; Harrigan MR; Fisher WS; Tubbs RS; Shoja MM; Griessenauer CJ
    J Neurosurg; 2017 May; 126(5):1530-1536. PubMed ID: 27177181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Utility of Ankle-Brachial Index as a Predictor of Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage.
    Guan J; Karsy M; Brock A; Couldwell WT
    World Neurosurg; 2016 May; 89():139-46. PubMed ID: 26828462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised controlled trial of induced hypermagnesaemia following aneurysmal subarachnoid haemorrhage.
    Bradford CM; Finfer S; O'Connor A; Yarad E; Firth R; McCallister R; Harrington T; Steinfort B; Faulder K; Assaad N; Morgan M
    Crit Care Resusc; 2013 Jun; 15(2):119-25. PubMed ID: 23931043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Admission neutrophil-lymphocyte ratio predicts delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage.
    Al-Mufti F; Amuluru K; Damodara N; Dodson V; Roh D; Agarwal S; Meyers PM; Connolly ES; Schmidt MJ; Claassen J; Park S
    J Neurointerv Surg; 2019 Nov; 11(11):1135-1140. PubMed ID: 30979846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.